๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A phase II trial of interferon alpha-2A plus fluorouracil in advanced renal cell carcinoma

โœ Scribed by Brian R. Murphy; Susan M. Rynard; Lawrence H. Einhorn; Patrick J. Loehrer

Publisher
Springer US
Year
1992
Tongue
English
Weight
499 KB
Volume
10
Category
Article
ISSN
0167-6997

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

A phase II trial of interferon-ฮฑ and 5-f
A phase II trial of interferon-ฮฑ and 5-fluorouracil in patients with advanced renal cell carcinoma: A Southwest Oncology Group study
โœ Laurence Elias; Brent A. Blumenstein; Julie Kish; Robert C. Flanigan; James L. W ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 355 KB ๐Ÿ‘ 1 views

## BACKGROUND. Renal cell carcinoma is a common neoplasm that is often refractory to treatment. It is occasionally responsive to immunoniodulating agents including interferon-a, which enhances the effects of 5-fluorouracil upon cells. Combinations of these two drugs have been most frequently tested

A Phase II trial of 5-fluorouracil and r
A Phase II trial of 5-fluorouracil and recombinant alpha-2a-interferon in previously untreated metastatic gastric carcinoma
โœ Richard Pazdur; Jaffer A. Ajani; Rodger Winn; James Bearden; Robert J. Belt; Sus ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 468 KB ๐Ÿ‘ 3 views

A Phase I1 clinical trial of the combination of 5-fluorouracil (5-FU) and recombinant alpha-2a-interferon (a-2a-IFN) was conducted in 44 patients. Patients had not received chemotherapy previously and had measurable metastatic gastric carcinoma. 5-FU was administered as a continuous infusion at a do